Thrice-weekly Versus Thrice-daily Oral Ferrous Fumarate Treatment in Adult Patients With Iron Deficiency Anemia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Iron deficiency anemia is a global health problem and the most common cause of anemia
worldwide. Patients with iron deficiency and Iron deficiency anemia can present with a
multitude of symptoms including fatigue, dyspnea on exertion, dysphagia, pallor,
palpitations, headaches, tinnitus, taste disturbance and pica. Oral iron supplementation is
associated with increasing hemoglobin in multiple studies in women, pregnant women and
elderly patients. However, the optimal dose and frequency of oral iron supplementation for
treatment remains unclear. The current proposed study attempts to address this gap in the
literature.